MOLECULAR PARTNERS AG Increase Decrease In Net Defined Benefit Liability Asset Resulting From Expense Income In Profit Or Loss
MOLECULAR PARTNERS AG (MOLN) reported Increase Decrease In Net Defined Benefit Liability Asset Resulting From Expense Income In Profit Or Loss of CHF 1.60 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss · last filed 2026-03-12
| Period end | Increase Decrease In Net Defined Benefit Liability Asset Resulting From Expense Income In Profit Or Loss 12 month |
|---|---|
| 2025-12-31 | 1.60M CHF 20-F · filed 2026-03-12 |
| 2024-12-31 | 1.47M CHF 20-F · filed 2026-03-12 |
| 2023-12-31 | 2.63M CHF 20-F · filed 2025-03-06 |
| 2022-12-31 | 3.19M CHF 20-F · filed 2024-03-14 |
| 2021-12-31 | 3.06M CHF 20-F · filed 2023-03-09 |
| 2020-12-31 | 3.08M CHF 20-F · filed 2022-03-15 |